Suven Pharmaceuticals Limited (NSE: SUVENPHAR)

Suven Pharmaceuticals Ratios and Metrics

Market cap in millions INR. Fiscal year is April - March.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 6, 2024	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020
Market Capitalization	305,516	172,366	120,256	157,436	126,468	25,590
Market Cap Growth	65.48%	43.33%	-23.62%	24.49%	394.21%	-
Enterprise Value	297,955	165,176	117,048	156,449	127,128	25,590
Last Close Price	1200.15	677.10	472.40	608.53	484.99	97.94
PE Ratio	127.04	57.40	29.24	34.14	34.08	7.87
PS Ratio	32.69	16.39	8.97	11.92	12.53	3.07
PB Ratio	14.90	8.41	6.93	10.31	10.71	3.03
P/FCF Ratio	-	56.20	70.21	61.78	46.55	8.42
P/OCF Ratio	-	48.08	26.30	47.71	33.06	6.29
EV/Sales Ratio	31.88	15.71	8.73	11.85	12.59	3.07
EV/EBITDA Ratio	93.39	40.65	20.44	27.00	28.85	6.70
EV/EBIT Ratio	112.06	46.59	22.24	28.88	31.01	7.14
EV/FCF Ratio	-	53.86	68.34	61.40	46.79	8.42
Debt / Equity Ratio	0.03	0.03	0.04	0.06	0.12	0.22
Debt / EBITDA Ratio	0.20	0.16	0.12	0.17	0.32	0.49
Debt / FCF Ratio	-	0.21	0.41	0.38	0.53	0.61
Asset Turnover	-	0.50	0.71	0.80	0.76	0.85
Inventory Turnover	-	1.60	1.87	2.24	2.19	1.93
Quick Ratio	-	9.46	4.17	3.85	1.56	0.98
Current Ratio	-	11.82	6.37	5.36	2.57	1.95
Return on Equity (ROE)	-	15.86%	25.21%	33.52%	35.78%	44.18%
Return on Assets (ROA)	-	10.50%	17.33%	20.49%	19.35%	22.90%
Return on Capital (ROIC)	8.48%	11.30%	19.18%	22.96%	21.76%	26.29%
Earnings Yield	0.79%	1.74%	3.42%	2.88%	2.87%	12.39%
FCF Yield	1.78%	1.42%	1.62%	2.15%	11.87%
Dividend Yield	0.00%	-	-	0.33%	0.41%	1.28%
Payout Ratio	0.00%	-	49.52%	11.22%	7.03%	10.04%
Buyback Yield / Dilution	-0.05%	-	-	-	0.00%	-0.00%
Total Shareholder Return	-0.05%	-	-	0.33%	0.41%	1.28%

Source: S&P Capital IQ. Standard template. Financial Sources.